Gwenn Hansen insider trades: Nurix Therapeutics (NRIX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gwenn reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | NRIX | ↓ Sell | 5,409 | $26.42 | $143K | Direct | Nov 2, 2026 (0d) |
| Oct 15, 2026 | NRIX | ↓ Sell | 1,452 | $25.00 | $36K | Direct | Oct 15, 2026 (0d) |
| Sep 1, 2026 | NRIX | ↓ Sell | 1,452 | $25.47 | $37K | Direct | Sep 1, 2026 (0d) |
| Aug 5, 2026 | NRIX | ↓ Sell | 4,356 | $25.00 | $109K | Direct | Aug 5, 2026 (0d) |
| Aug 4, 2026 | NRIX | ↓ Sell | 4,111 | $24.36 | $100K | Direct | Aug 5, 2026 (1d) |
| Jul 30, 2026 | NRIX | ↓ Sell | 3,847 | $23.38 | $90K | Direct | Jul 30, 2026 (0d) |
| Apr 30, 2026 | NRIX | ↓ Sell | 3,214 | $16.65 | $53K | Direct | Apr 30, 2026 (0d) |
| Jan 30, 2026 | NRIX | ↓ Sell | 4,895 | $16.60 | $81K | Direct | Jan 30, 2026 (0d) |
| Oct 30, 2025 | NRIX | ↓ Sell | 4,087 | $12.80 | $52K | Direct | Oct 30, 2025 (0d) |
| Jul 30, 2025 | NRIX | ↓ Sell | 4,308 | $12.01 | $52K | Direct | Jul 30, 2025 (0d) |
| Apr 30, 2025 | NRIX | ↓ Sell | 3,377 | $11.50 | $39K | Direct | Apr 30, 2025 (0d) |
| Jan 30, 2025 | NRIX | ↓ Sell | 3,690 | $19.85 | $73K | Direct | Jan 30, 2025 (0d) |
| Oct 30, 2024 | NRIX | ↓ Sell | 3,437 | $24.30 | $84K | Direct | Oct 30, 2024 (0d) |
| Jul 30, 2024 | NRIX | ↓ Sell | 3,408 | $20.67 | $70K | Direct | Jul 30, 2024 (0d) |
| Apr 30, 2024 | NRIX | ↓ Sell | 2,007 | $12.04 | $24K | Direct | Apr 30, 2024 (0d) |
| Jan 30, 2024 | NRIX | ↓ Sell | 2,334 | $7.99 | $19K | Direct | Jan 30, 2024 (0d) |
| Oct 31, 2023 | NRIX | ↓ Sell | 1,633 | $5.20 | $8K | Direct | Nov 1, 2023 (1d) |
| Jul 31, 2023 | NRIX | ↓ Sell | 1,884 | $9.65 | $18K | Direct | Aug 1, 2023 (1d) |
| May 1, 2023 | NRIX | ↓ Sell | 1,136 | $9.88 | $11K | Direct | May 2, 2023 (1d) |
| Jan 30, 2023 | NRIX | ↓ Sell | 1,412 | $11.78 | $17K | Direct | Feb 1, 2023 (2d) |
| Oct 31, 2022 | NRIX | ↓ Sell | 1,165 | $12.88 | $15K | Direct | Nov 1, 2022 (1d) |
| Aug 1, 2022 | NRIX | ↓ Sell | 1,186 | $15.67 | $19K | Direct | Aug 2, 2022 (1d) |
| May 2, 2022 | NRIX | ↓ Sell | 1,098 | $11.75 | $13K | Direct | May 3, 2022 (1d) |
| Jan 3, 2022 | NRIX | ↓ Sell | 1,828 | $28.96 | $53K | Direct | Jan 4, 2022 (1d) |
| Dec 1, 2021 | NRIX | ↓ Sell | 400 | $29.13 | $12K | Direct | Dec 2, 2021 (1d) |
| Nov 1, 2021 | NRIX | ↓ Sell | 400 | $33.24 | $13K | Direct | Nov 2, 2021 (1d) |
| Oct 27, 2021 | NRIX | ↓ Sell | 400 | $35.00 | $14K | Direct | Oct 28, 2021 (1d) |
| Oct 1, 2021 | NRIX | ↓ Sell | 400 | $29.92 | $12K | Direct | Oct 4, 2021 (3d) |
| Sep 7, 2021 | NRIX | ↓ Sell | 1,600 | $35.00 | $56K | Direct | Sep 8, 2021 (1d) |
| Sep 1, 2021 | NRIX | ↓ Sell | 400 | $32.34 | $13K | Direct | Sep 2, 2021 (1d) |
| Aug 2, 2021 | NRIX | ↓ Sell | 400 | $31.21 | $12K | Direct | Aug 3, 2021 (1d) |
| Jul 1, 2021 | NRIX | ↓ Sell | 400 | $26.76 | $11K | Direct | Jul 2, 2021 (1d) |
| Jun 1, 2021 | NRIX | ↓ Sell | 400 | $27.74 | $11K | Direct | Jun 2, 2021 (1d) |
| May 3, 2021 | NRIX | ↓ Sell | 800 | $34.99 | $28K | Direct | May 4, 2021 (1d) |
| Apr 5, 2021 | NRIX | ↓ Sell | 400 | $35.00 | $14K | Direct | Apr 6, 2021 (1d) |
| Apr 1, 2021 | NRIX | ↓ Sell | 400 | $31.55 | $13K | Direct | Apr 2, 2021 (1d) |
| Mar 16, 2021 | NRIX | ↓ Sell | 800 | $45.00 | $36K | Direct | Mar 16, 2021 (0d) |
| Mar 1, 2021 | NRIX | ↓ Sell | 800 | $35.95 | $29K | Direct | Mar 2, 2021 (1d) |
| Feb 18, 2021 | NRIX | ↓ Sell | 800 | $36.27 | $29K | Direct | Feb 22, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NRIX insiders
Open-market trades in the last 12 months
About Gwenn Hansen's insider trades
Gwenn Hansen is Chief Scientific Officer at Nurix Therapeutics (NRIX). Since Feb 18, 2021, Gwenn has reported no open-market purchases and 39 sales worth $1.5M on SEC Form 4. In the last 12 months: 8 sales ($650K).
Their filings also include option exercises (40 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.